News and Trends 11 Jun 2019
Janssen and Genmab Team Up Again for Another Potential Cancer Blockbuster
Janssen and the Danish biotech Genmab will collaborate to develop a new antibody that could outperform their blockbuster cancer drug Darzalex in certain types of blood cancer. Genmab will develop…